steno-occlusive disease of the vertebral and basilar artery.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 years or older; 2. Patients with ischaemic stroke or TIA in the perfusion territory of the vertebo-basilar arteries.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or possible pregnancy; 2. Implanted stent(s); 3. Severe liver or renal dysfunction; 4. Addison’s disease; 5. Allergic reaction for sulfonamides; 6. Cor pulmonale; 7. Longobstruction / emfysema; 8. Primary hyperaldosteronisme; 9. Fenytoïne, primidon and/or fenobarbital use; 10. Japanese and Indian subjects or subjects of Japanese descent; 11. Impossibility to undergo MRI (claustrophobia, metal objects in or around the body).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is cerebrovascular reactivity measured with MR imaging at 3 Tesla using a visual stimulus and administration of vasodilatory challenge medication to induce hemodynamic stress. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include cerebral blood flow and perfusion territories of the brain feeding arteries. | — |
Contacts
PO Box 85500